Navigation Links
Experimental Drug Fails Against Heart Failure
Date:11/6/2007

Tezosentan didn't change outcomes for patients with sudden, life-threatening attacks, trial shows

TUESDAY, Nov. 6 (HealthDay News) -- An experimental kind of medication has failed as treatment for the emergency condition known as acute heart failure, a new trial finds.

The drug, tezosentan, did not improve patients' breathlessness, reduce their incidence of major cardiovascular events, or cut their risk of death after acute heart failure, concludes an international study published in the Nov. 7 issue of the Journal of the American Medical Association.

"This is an investigational new drug that is an endothelin receptor blocker," explained study co-author Dr. John R. Teerlink, an associate professor of medicine at the University of California, San Francisco.

Endothelin is "one of the most potent vasoconstrictors known," Teerlink said, meaning that it causes blood vessels to become narrower. In fact, it has similar properties to snake venom, he said.

Episodes of acute heart failure can occur in people with chronic heart failure, in which the heart slowly loses the ability to pump blood. The loss of that ability occurs suddenly in an acute episode, leaving a person gasping for breath. The lungs can fill rapidly with fluid, and the episode can be fatal.

While chronic heart failure is routinely managed with a variety of drugs, including beta blockers and fluid-reducing diuretics, "all the available agents for acute heart failure have significant side effects," Teerlink said.

Many existing medications, such as nitroglycerin, act by causing blood vessels to become wider, improving blood low. Tezosentan would act differently, by preventing blood vessels from narrowing.

In the study, more than 1,400 people who suffered episodes of acute heart failure were either given infusions of tezosentan for up to 72 hours or a placebo.

The drug did not improve breathlessness m
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
2. Experimental Antidepressants Offer Faster Relief
3. Experimental drug shows promise in advanced kidney cancer
4. Experimental drug boosts survival in recurrent ovarian cancer
5. Experimental cancer pharmaceuticals under trial
6. Federal research plan to determine nanotech risks fails to deliver
7. States HMO Report Card Fails in Meaningful Evaluation of Health Care Quality and Ignores Affordability
8. Emergency Care for Heart Attacks, Pneumonia Fails to Meet Goals
9. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
10. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
11. Despite overeating, morbidly obese mice gain protection against diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental Drug Fails Against Heart Failure
(Date:9/2/2015)... Newark, NJ (PRWEB) , ... September 02, 2015 , ... ... as Horizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ) donated $11,000 to ... initial $5,000 donation to the foundation at the start of The Barclays, Horizon BCBSNJ ...
(Date:9/2/2015)... ... September 02, 2015 , ... The Hydration ... allopathic medicine, opens its second location this week at 31542 S. Coast Hwy, ... feet of lounge space for patients to relax while receiving safe and effective ...
(Date:9/2/2015)... Appleton, WI (PRWEB) , ... September 02, 2015 ... ... Midwest, Cypress Benefit Administrators is taking action after seeing a significant ... The TPA’s Argus Claim Review division has found many cases of OON ASCs ...
(Date:9/2/2015)... KS (PRWEB) , ... September 02, 2015 , ... Amada ... its newest office in Kansas – its Johnson County location. Amada franchise ... healthcare. Mike has a registered nurse background and spent over 20 years in medical ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... imaging, content, records and case management solutions and services to both government and ... Image Re-sizing and Image Clean-up utility for IBM’s Datacap document capture platform. ...
Breaking Medicine News(10 mins):Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 2Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 3Health News:The Hydration Room Opens New Location In Laguna Beach, California 2Health News:The Hydration Room Opens New Location In Laguna Beach, California 3Health News:The Hydration Room Opens New Location In Laguna Beach, California 4Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3Health News:Amada Senior Care Expands to Greater Kansas City 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3
... ... market with the release of their new ReActive™ Court Surface. , ... Salt Lake City, Utah (PRWEB) February 7, 2010 -- ... primary advantage of the new system is its adherence to metric standards, while still utilizing ...
... translates to success on playing field, author says , FRIDAY. ... odds of becoming a professional athlete, a new study suggests. ... League (AFL) players and found that many were born in ... born in the later months. , The Australian school year ...
... ... offering plastic surgery in Phoenix . For women who are interested in enhancing the ... with breast implants. , ... AZ (Vocus) February 6, 2010 -- Over the course of his career, Dr. Steven Turkeltaub ...
... ... Possibilities And Cost Savings for the Funeral Home , ... Waunakee, WI (PRWEB) February 6, 2010 -- When you are saying ... At today’s funerals, you might hear the buzzword “personalization” but you might not be sure ...
... CHICAGO, Ill. (February 6, 2010) In a study to ... annual meeting, The Pregnancy Meeting , in Chicago, researchers will ... of intrauterine fetal death (IUFD), commonly known as stillbirth, in ... rare and affects only six to seven out of every ...
... ... their Creams N, Lotions Facebook page or followers of their Twitter handle, @100sheabutter. Five randomly ... , ... 5, 2010 -- Reforma Group is announcing a special Valentine,s Day giveaway to fans of ...
Cached Medicine News:Health News:SnapSports Releases ReActive Court Surfacing For The International Sports Market 2Health News:Kids Born Early in Year More Likely to Be Athletes? 2Health News:Is Breast Augmentation Surgery Right for Me? Arizona Breast Surgeon Discusses Various Breast Procedures 2Health News:Is Breast Augmentation Surgery Right for Me? Arizona Breast Surgeon Discusses Various Breast Procedures 3Health News:Frazer Consultants Riding the New Wave in Funeral Home Stationery 2Health News:Study finds higher risk of stillbirth in women with fibroids 2Health News:Romantic Valentine's Day Gift Ideas: Keep Your Skin Soft & Naughty Gift Basket Giveaway 2
(Date:9/2/2015)...  MEI Pharma, Inc. (Nasdaq: MEIP ), an ... therapies for cancer, today announced results for its fiscal ... http://photos.prnewswire.com/prnh/20140805/133834 "Despite a challenging ... with how the Company is positioned entering fiscal year ... and Chief Executive Officer of MEI Pharma. "While we ...
(Date:9/2/2015)... LAVAL, Quebec , Sept. 2, 2015  Valeant ... VRX) today announced that its affiliate has entered into ... USA , Inc. (NASDAQ: SURG ... to the upfront cash payment, Synergetics stockholders will receive ... if specified sales milestones are achieved following the closing.  ...
(Date:9/2/2015)... , Sept. 2, 2015 Relmada Therapeutics, Inc. ... for the treatment of chronic pain, announced today that ... both the FBR Second Annual Healthcare Conference and BioCentury ... FBR Second Annual Healthcare Conference Date:  ... Boston No presentation, investor meetings only ...
Breaking Medicine Technology:MEI Pharma Reports Fiscal Year 2015 Results 2MEI Pharma Reports Fiscal Year 2015 Results 3MEI Pharma Reports Fiscal Year 2015 Results 4MEI Pharma Reports Fiscal Year 2015 Results 5MEI Pharma Reports Fiscal Year 2015 Results 6MEI Pharma Reports Fiscal Year 2015 Results 7Valeant Pharmaceuticals To Acquire Synergetics USA 2Valeant Pharmaceuticals To Acquire Synergetics USA 3Valeant Pharmaceuticals To Acquire Synergetics USA 4Valeant Pharmaceuticals To Acquire Synergetics USA 5Relmada Therapeutics to Participate in Two Upcoming Investor Conferences 2
... 2011 The Food and Drug Administration (FDA) has recently issued safety ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) a wart and mole remover ... as a "sexual enhancer" a diabetes medicine that carries an ... a child,s IQ when taken by the mother while pregnant ...
... July 25, 2011 Waters Corporation (NYSE: ... for increasing clinical laboratory efficiencies including the first ... of everolimus (Certican®). (Logo: http://photos.prnewswire.com/prnh/20110707/NE31586LOGO) ... these exciting new products. MassTrak™ ...
Cached Medicine Technology:FDA CONSUMER HEALTH INFORMATION - FDA's MedWatch Safety Alerts: June 2011 2Waters Showcases ACQUITY UltraPerformance LC and Mass Spectrometry (UPLC/MS) Tools for Increasing Laboratory Efficiency at the American Association for Clinical Chemistry Annual Meeting 2Waters Showcases ACQUITY UltraPerformance LC and Mass Spectrometry (UPLC/MS) Tools for Increasing Laboratory Efficiency at the American Association for Clinical Chemistry Annual Meeting 3
Coat-A-Count PAP IRMA,is an immunoradiometric assay designed,for the quantitative measurement of,prostatic acid phosphatase (PAP) in,serum. It is intended strictly for in vitro,diagnostic u...
For in vitro diagnostic use,with the IMMULITE 2000 Analyzer for,the quantitative measurement of prostatic,acid phosphatase (PAP) in serum, as an,aid in patient management....
Abbott offers an array of both in-vitro and molecular diagnostic tests for the detection and monitoring of cancerous conditions in patients....
For the quantitative measurement of human prostatic acid phosphatase (PAP) in human serum....
Medicine Products: